• Covid-19: MannKind, Pneumagen conduct research pharmaceutical-technology
    March 19, 2020
    MannKind has shifted the research and development (R&D) resources allotted for its lung diseases pipeline to help fight respiratory viral infections, including Covid-19.
PharmaSources Customer Service